Apac Medical Aesthetics Market
Marktgröße in Milliarden USD
CAGR :
% 
 Prognosezeitraum |
2024 –2030 |
 Marktgröße (Basisjahr) | |
 Marktgröße (Prognosejahr) | USD 9,744.43 |
 CAGR |
% |
| Wichtige Marktteilnehmer |
Asia-Pacific Medical Aesthetics Market, By Product Type (Aesthetic Laser Devices, Energy Devices, Body Contouring Devices, Facial Aesthetic Devices, Aesthetic Implants, and Skin Aesthetic Devices), Application (Anti-Aging and Wrinkles, Facial and Skin Rejuvenation, Breast Enhancement, Body Shaping and Cellulite, Tattoo Removal, Vascular Lesions, Sears, Pigment Lesions, Reconstructive, Psoriasis, and Vitiligo and Others), End User (Cosmetic Centers, Dermatology Clinics, Hospitals, Medical Spas, and Beauty Centers), Distribution Channel (Direct Tender and Retail Sales)- Industry Trends and Forecast to 2030.
Asia-Pacific Medical Aesthetics Market Analysis and Size
The Asia-Pacific medical aesthetics market is fragmented, as it consists of many Asia-Pacific players such as ALLERGAN, Bausch Health Companies Inc., Lumenis, Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Cynosure, Cutera, and Mentor Worldwide LLC among others. The presence of these companies produces competitive prices for medical aesthetics products across the region. Due to the presence of these players at regional and international levels, suppliers and manufacturers offer products with different specifications and characteristics in all budgets. The rising technological advancements are driving the market growth. Additionally, key market players' strategic initiatives are expected to drive market growth.
Data Bridge Market Research analyzes that the Asia-Pacific medical aesthetics market is expected to reach a value of USD 9,744.43 million by 2030, at a CAGR of 13.7% during the forecast period. This market report also covers pricing analysis and technological advancements in depth.
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015 - 2020) |
|
Quantitative Units |
Revenue in Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Product Type (Aesthetic Laser Devices, Energy Devices, Body Contouring Devices, Facial Aesthetic Devices, Aesthetic Implants, and Skin Aesthetic Devices), Application (Anti-Aging and Wrinkles, Facial and Skin Rejuvenation, Breast Enhancement, Body Shaping and Cellulite, Tattoo Removal, Vascular Lesions, Sears, Pigment Lesions, Reconstructive, Psoriasis, and Vitiligo and Others), End User (Cosmetic Centers, Dermatology Clinics, Hospitals, Medical Spas, and Beauty Centers), Distribution Channel (Direct Tender and Retail Sales) |
|
Countries Covered |
Japan, India, China, South Korea, Australia, Thailand, Singapore, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific |
|
Market Players Covered |
Allergan, Bausch Health Companies Inc., Lumenis, Shanghai Fosun Pharmaceutical（Group）Co. Ltd., Syneron Medical Ltd, BTL, Cutera, Eclipse, Lutronic, Mentor Worldwide LLC, Merz Pharma, Sciton Inc., Sharplight Technologies Inc, Syneron Medical Ltd., Venus Concept among others |
Market Definition
Aesthetic devices are an innovative advancement, providing a solution to patients with the ingenuity of creating beauty. Medical aesthetics devices are a growing market owing to their benefits such as maintaining a youthful appearance, pain-free and non-invasive beauty treatments, maintenance-free skin that remains smooth and hairless without the need for shaving, waxing, or unpleasant hair treatments, improving the cosmetic appearance, and technological advancement in medical aesthetics devices.
Medical aesthetics devices are a cosmetic treatment that improves appearance by treating conditions such as acne, unwanted hair, wrinkles, sunspots, and others. The benefits are improved appearance, better health, immediate and long-lasting results, increased self-esteem, and others.
Asia-Pacific Medical Aesthetics Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
DRIVERS
Aging Population Asia-Pacific
The sole objective of aesthetic surgery in the aging population is to improve psychological well-being by improving or modifying their body image. The normal body structures are reshaped to accomplish this goal. The aesthetic surgery has successfully improved the quality-of-life-index and reduced depression amongst the elderly population. The growth of the aging population Asia-Pacific has led to the growth of the medical aesthetics market. There has been massive growth in the looks industry in recent years, and the aging population has been one of the drivers in this process. The superficial goal of the perfect body depicted by mass media is a major reason for its growth. People's obsession with looking more youthful leads to various breakthroughs in the aesthetic market.
Technological Advancements
The Asia-Pacific medical aesthetics market is booming because of awareness among prospective customers. The drive to possess the perfect figure and shape humans paces the aesthetics market with innovative technological advancements. The aesthetics market itself has been able to attract a huge number of customers Asia-Pacific. Medical Aesthetics have redefined the definition of perfection. With the increase in technological advancements, there is a reduction in side effects and better quality treatments. This, along with increasing awareness among people, drives the Asia-Pacific medical aesthetics market.
OPPORTUNITY
Imminent Health Revolution
The standard of living in developing countries such as India, Brazil, South Africa, Thailand, and many others has improved in the past decade. People opt for different aesthetic surgeries to maintain themselves, giving them better results without stressful physical efforts. The Asia-Pacific medical aesthetics market remains unexplored in many countries, but the increase in awareness about it amongst emerging countries is leading to its further growth.
RESTRAINT/CHALLENGE
Regulatory scenario
Every medical aesthetics company, no matter how big or small or which market it covers, must adhere to the regulatory requirements. Medical aesthetics is under stringent government regulations. The manufacturers of medical aesthetic devices and products must go through various testing levels before the final validation. Complying with the FDA's standards requires specialized skill sets, resources, time, and money. Medical aesthetics are subjected to pre-market approval application (PMA) per the Federal Food, Drug, and Cosmetic Act (FFDC) and its regulations.
Post-COVID-19 Impact on the Asia-Pacific Medical Aesthetics Market
COVID-19 negatively impacted the Asia-Pacific medical aesthetics market due to the shutdown of Asia-Pacific manufacturing sectors, logistics and transportation, and lack of testing for the product.
The COVID-19 pandemic has impacted the market to an extent negative manner. However, increasing government support and continuous technological advancement are expected to provide lucrative opportunities for market growth. Moreover, increasing partnerships, acquisitions, and collaboration among market players and the growing awareness of medical aesthetics products in the region are expected to fuel the market growth further. Also, the growth has been high since the market opened after COVID-19, and it is expected that there will be considerable growth in the sector. The market players are conducting multiple R&D activities to improve the technology involved in the product. With this, the companies will bring advancement and innovation to the market.
Recent Developments
- In February 2022, Allergan (a subsidiary of AbbVie Inc.) announced the FDA approval of JUVÉDERM VOLBELLA XC to improve infraorbital hollows in adults above 21. This helped the company to expand the product portfolio of aesthetics in the U.S. market.
- In January 2022, Mentor Worldwide LLC (a subsidiary of the Johnson & Johnson Medical Devices Companies) announced that the FDA had approved the MENTOR MemoryGel BOOST breast implant for breast augmentation and breast reconstruction. This product has helped the company to expand its product portfolio of aesthetics in the U.S. market.
Asia-Pacific Medical Aesthetics Market Scope
The Asia-Pacific medical aesthetics market is segmented into four notable segments based on product type, application, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and insights to help them make strategic decisions for identifying core market applications.
By Product Type
- Aesthetic Laser Devices
- Energy Devices
- Body Contouring Devices
- Facial Aesthetic Devices
- Aesthetic Implants
- Skin Aesthetic Devices
Based on product type, the market is segmented into aesthetic laser devices, energy devices, body contouring devices, facial aesthetic devices, aesthetic implants, and skin aesthetic devices.
By Application
- Anti-Aging and Wrinkles
- Facial and Skin Rejuvenation
- Breast Enhancement
- Body Shaping and Cellulite
- Tattoo Removal
- Vascular Lesions
- Sears, Pigment Lesions Reconstructive
- Psoriasis and Vitiligo
- Others
Based on application, the market is segmented into anti-aging and wrinkles, facial and skin rejuvenation, breast enhancement, body shaping and cellulite, tattoo removal, vascular lesions, sears, pigment lesions, reconstructive, psoriasis and vitiligo and others.
By End User
- Cosmetic Centers
- Dermatology Clinics
- Hospitals
- Medical Spas and Beauty Centers
Based on end user, the market is segmented into cosmetic centers, dermatology clinics, hospitals, medical spas and beauty centers.
By Distribution Channel
- Direct tender
- Retail Sales
Based on distribution channel, the market is segmented into direct tender and retail, sales.
Asia-Pacific Medical Aesthetics Market Regional Analysis/Insights
The Asia-Pacific medical aesthetics market is analyzed, and market size insights and trends are provided by country, product type, application, end user, and distribution channel, as referenced above.
The countries covered in this market report are Japan, India, China, South Korea, Australia, Thailand, Singapore, Malaysia, Indonesia, Philippines, and Rest of Asia-Pacific.
Japan is expected to dominate the market with the largest market share. This share is attributable to the presence of key market players such as Allergan, Bausch Health Companies Inc., and Lumenis among others. Strategic initiatives by key market players and penetration of new technologies are anticipated to fuel the market growth during the forecast period in the country.
The country section of the report also provides individual market-impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends, porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Asia-Pacific Medical Aesthetics Market Share Analysis
The Asia-Pacific medical aesthetics market competitive landscape provides details of the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, Asia-Pacific presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major market players operating in the Asia-Pacific medical aesthetics market are Allergan, Bausch Health Companies Inc., Lumenis, Shanghai Fosun Pharmaceutical（Group）Co. Ltd., Syneron Medical Ltd, BTL, Cutera, Lutronic, Mentor Worldwide LLC among others.
SKU-
Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud
- Interaktives Datenanalyse-Dashboard
- Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
- Zugriff für Research-Analysten für Anpassungen und Abfragen
- Konkurrenzanalyse mit interaktivem Dashboard
- Aktuelle Nachrichten, Updates und Trendanalyse
- Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Inhaltsverzeichnis
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA PACIFIC MEDICAL AESTHETICS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
4.3 CUSTOMISED DATA:
4.3.1 INTRODUCTION
5 ASIA PACIFIC MEDICAL AESTHETICS MARKET, REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 AGING POPULATION ASIA PACIFICLY
6.1.2 TECHNOLOGICAL ADVANCEMENTS
6.1.3 KEY PLAYERS ARE TAKING STRATEGIC DECISIONS TO GAIN MARKET SHARE
6.2 RESTRAINTS
6.2.1 STRINGENT REGULATORY POLICIES
6.2.2 HIGH COST FOR THE TREATMENTS.
6.3 OPPORTUNITIES
6.3.1 IMMENT HEALTH REVOLUTION
6.3.2 GROWING MEDICAL TOURISM IN ASIA
6.4 CHALLENGE
6.4.1 INCREASING COMPETITORS
7 ASIA PACIFIC MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 AESTHETIC LASER DEVICES
7.2.1 ABLATIVE SKIN RESURFACING DEVICES
7.2.1.1 CO2 LASER
7.2.1.2 ERBIUM LASER
7.2.1.3 OTHERS
7.2.2 NON-ABLATIVE FRACTIONAL LASER RESURFACING DEVICES
7.2.2.1 RADIOFREQUENCY
7.2.2.2 INTENSE PULSED LIGHT
7.2.2.3 FRACTIONAL LASER
7.2.2.4 THE Q-SWITCHED ND:YAG LASER
7.2.2.5 OTHERS
7.3 ENERGY DEVICES
7.3.1 LASER SURGERY DEVICES
7.3.2 ELECTROCAUTERY DEVICES
7.3.3 ELECTROSURGERY DEVICES
7.3.4 CRYOSURGERY DEVICES
7.3.5 HARMONIC SCALPEL
7.3.6 MICROWAVE DEVICES
7.4 BODY CONTOURING DEVICES
7.4.1 LIPOSUCTION
7.4.2 NONSURGICAL SKIN TIGHTENING
7.4.3 CELLULITE TREATMENT
7.5 FACIAL AESTHETIC DEVICES
7.5.1 BOTOX INJECTION
7.5.2 DERMAL FILLERS
7.5.2.1 NATURAL DERMAL FILLERS
7.5.2.2 SYNTHETIC DERMAL FILLERS
7.5.3 COLLAGEN INJECTIONS
7.5.4 CHEMICAL PEEL
7.5.5 FACIAL TONING
7.5.6 FRAXEL
7.5.7 COSMETIC ACUPUNCTURE
7.5.8 ELECTROTHERAPY
7.5.9 MICRODERMABRASION
7.5.10 PERMANENT MAKEUP
7.6 AESTHETIC IMPLANTS
7.6.1 BREAST AUGMENTATION
7.6.1.1 SALINE IMPLANTS
7.6.1.2 SILICON IMPLANTS
7.6.2 BUTTOCK AUGMENTATION
7.6.3 AESTHETIC DENTAL IMPLANTS
7.6.3.1 DENTAL TITANIUM IMPLANTS
7.6.3.2 DENTAL ZERCONIUM IMPLANTS
7.6.4 FACIAL IMPLANTS
7.6.5 SOFT TISSUE IMPLANTS
7.6.6 TRANSDERMAL IMPLANT
7.6.7 OTHERS
7.7 SKIN AESTHETIC DEVICES
7.7.1 LASER SKIN RESURFACING DEVICES
7.7.2 NON SURGICAL SKIN TIGHTENING DEVICES
7.7.3 LIGHT THERAPY DEVICES
7.7.4 TATTOO REMOVAL DEVICES
7.7.5 MICRO-NEEDLING PRODUCTS
7.7.6 THREAD LIFT PRODUCTS
7.7.7 NAIL TREATMENT LASER DEVICES
7.7.8 OTHERS
8 ASIA PACIFIC MEDICAL AESTHETICS MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 ANTI-AGING AND WRINKLES
8.3 FACIAL AND SKIN REJUVENATION
8.4 BREAST ENHANCEMENT
8.5 BODY SHAPING AND CELLULITE
8.6 TATTOO REMOVAL
8.7 VASCULAR LESIONS
8.7.1 SEARS, PIGMENT LESIONS, RECONSTRUCTIVE
8.8 PSORIASIS AND VITILIGO
8.9 OTHERS
9 ASIA PACIFIC MEDICAL AESTHETICS MARKET, BY END USER
9.1 OVERVIEW
9.2 COSMETIC CENTERS
9.3 DERMATOLOGY CLINICS
9.4 HOSPITALS
9.5 MEDICAL SPAS AND BEAUTY CENTERS
10 ASIA PACIFIC MEDICAL AESTHETICS MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 DIRECT TENDER
10.3 RETAIL
11 ASIA PACIFIC MEDICAL AESTHETIC DEVICES MARKET, BY REGION
11.1 ASIA PACIFIC
11.1.1 CHINA
11.1.2 INDIA
11.1.3 JAPAN
11.1.4 SOUTH KOREA
11.1.5 SINGAPORE
11.1.6 THAILAND
11.1.7 MALAYSIA
11.1.8 INDONESIA
11.1.9 AUSTRALIA
11.1.10 PHILIPPINES
11.1.11 REST OF ASIA-PACIFIC
12 ASIA PACIFIC MEDICAL AESTHETICS MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
13 COMPANY PROFILE
13.1 ALLERGAN
13.1.1 COMPANY SNAPSHOT
13.1.2 SWOT ANALYSIS
13.1.3 REVENUE ANALYSIS
13.1.4 COMPANY SHARE ANALYSIS
13.1.5 PRODUCT PORTFOLIO
13.1.6 RECENT DEVELOPMENTS
13.1.7 DATA BRIDGE MARKET RESEARCH ANALYSIS
13.2 BAUSCH HEALTH COMPANIES INC.
13.2.1 COMPANY SNAPSHOT
13.2.2 SWOT ANALYSIS
13.2.3 REVENUE ANALYSIS
13.2.4 PRODUCT PORTFOLIO
13.2.5 RECENT DEVELOPMENTS
13.2.6 DATA BRIDGE MARKET RESEARCH ANALYSIS
13.3 LUMENIS
13.3.1 COMPANY SNAPSHOT
13.3.2 SWOT ANALYSIS
13.3.3 COMPANY SHARE ANALYSIS
13.3.4 PRODUCT PORTFOLIO
13.3.5 RECENT DEVELOPMENTS
13.3.6 DATA BRIDGE MARKET RESEARCH ANALYSIS
13.4 SHANGHAI FOSUN PHARMACEUTICAL(GROUP)CO., LTD.
13.4.1 COMPANY SNAPSHOT
13.4.2 SWOT ANALYSIS
13.4.3 REVENUE ANALYSIS
13.4.4 PRODUCT PORTFOLIO
13.4.5 RECENT DEVELOPMENTS
13.4.6 DATA BRIDGE MARKET RESEARCH ANALYSIS
13.5 CYNOSURE
13.5.1 COMPANY SNAPSHOT
13.5.2 SWOT ANALYSIS
13.5.3 COMPANY SHARE ANALYSIS
13.5.4 PRODUCT PORTFOLIO
13.5.5 RECENT DEVELOPMENTS
13.5.6 DATA BRIDGE MARKET RESEARCH ANALYSIS
13.6 AEROLASE CORP.
13.6.1 COMPANY SNAPSHOT
13.6.2 PRODUCT PORTFOLIO
13.6.3 RECENT DEVELOPMENTS
13.7 A.R.C. LASER GMBH
13.7.1 COMPANY SNAPSHOT
13.7.2 PRODUCT PORTFOLIO
13.7.3 RECENT DEVELOPMENT
13.8 ASCLEPION LASER TECHNOLOGIES GMBH
13.8.1 COMPANY SNAPSHOT
13.8.2 PRODUCT PORTFOLIO
13.8.3 RECENT DEVELOPMENT
13.9 BTL
13.9.1 COMPANY SNAPSHOT
13.9.2 PRODUCT PORTFOLIO
13.9.3 RECENT DEVELOPMENTS
13.1 CUTERA
13.10.1 COMPANY SNAPSHOT
13.10.2 REVENUE ANALYSIS
13.10.3 COMPANY SHARE ANALYSIS
13.10.4 PRODUCT PORTFOLIO
13.10.5 RECENT DEVELOPMENTS
13.11 ECLIPSE
13.11.1 COMPANY SNAPSHOT
13.11.2 PRODUCT PORTFOLIO
13.11.3 RECENT DEVELOPMENTS
13.12 LUTRONIC
13.12.1 COMPANY SNAPSHOT
13.12.2 PRODUCT PORTFOLIO
13.12.3 RECENT DEVELOPMENTS
13.13 MENTOR WORLDWIDE LLC
13.13.1 COMPANY SNAPSHOT
13.13.2 REVENUE ANALYSIS
13.13.3 COMPANY SHARE ANALYSIS
13.13.4 PRODUCT PORTFOLIO
13.13.5 RECENT DEVELOPMENT
13.14 MERZ PHARMA
13.14.1 COMPANY SNAPSHOT
13.14.2 PRODUCT PORTFOLIO
13.14.3 RECENT DEVELOPMENTS
13.15 QUANTA SYSTEM
13.15.1 COMPANY SNAPSHOT
13.15.2 PRODUCT PORTFOLIO
13.15.3 RECENT DEVELOPMENTS
13.16 SCITON INC.
13.16.1 COMPANY SNAPSHOT
13.16.2 PRODUCT PORTFOLIO
13.16.3 RECENT DEVELOPMENTS
13.17 SHARPLIGHT TECHNOLOGIES INC
13.17.1 COMPANY SNAPSHOT
13.17.2 PRODUCT PORTFOLIO
13.17.3 RECENT DEVELOPMENT
13.18 SYNERON MEDICAL LTD.
13.18.1 COMPANY SNAPSHOT
13.18.2 PRODUCT PORTFOLIO
13.18.3 RECENT DEVELOPMENTS
13.19 VENUS CONCEPT
13.19.1 COMPANY SNAPSHOT
13.19.2 PRODUCT PORTFOLIO
13.19.3 RECENT DEVELOPMENTS
14 QUESTIONNAIRE
15 RELATED REPORTS
Tabellenverzeichnis
TABLE 1 NUMBER OF WORLDWIDE SURGICAL PROCEDURES PERFORMED BY PLASTIC SURGEONS IN 2020
TABLE 2 NUMBER OF WORLDWIDE NON-SURGICAL PROCEDURES PERFORMED BY PLASTIC SURGEONS IN 2020
TABLE 3 IN 2020, THE TOTAL NUMBER OF SURGICAL PROCEDURES IN RUSSIA WAS 478,200.
TABLE 4 IN 2020, THE TOTAL NUMBER OF NON-SURGICAL PROCEDURES IN RUSSIA WAS 143,400.
TABLE 5 REGULATORY AUTHORITIES FOR MEDICAL AESTHETICS
TABLE 6 COST OF TREATMENT IN VARIOUS COUNTRIES
TABLE 7 THE FOLLOWING TABLE SHOWS THE TOTAL NUMBER OF PLASTIC SURGERIES OCCURRED IN DIFFERENT COUNTRIES:
TABLE 8 THE BELOW TABLE SHOWS THE AVERAGE SAVINGS ON THE TREATMENT AS COMPARED TO U.S.
TABLE 9 TABLE OF COST COMPARISON OF THE TREATMENT IN U.S. AND SHANGHAI
TABLE 10 ASIA PACIFIC MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 11 ASIA PACIFIC AESTHETIC LASER DEVICES IN MEDICAL AESTHETIC MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 12 ASIA PACIFIC AESTHETIC LASER DEVICES IN MEDICAL AESTHETIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 13 ASIA PACIFIC ABLATIVE RESURFACING DEVICES IN AESTHETIC LASER MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 14 ASIA PACIFIC NON-ABLATIVE RESURFACING DEVICES IN AESTHETIC LASER MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 15 ASIA PACIFIC ENERGY DEVICES IN MEDICAL AESTHETIC MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 16 ASIA PACIFIC ENERGY DEVICES IN MEDICAL AESTHETIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 17 ASIA PACIFIC BODY CONTOURING DEVICES IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 18 ASIA PACIFIC BODY CONTOURING DEVICES IN MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 19 ASIA PACIFIC FACIAL AESTHETIC DEVICES IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 20 ASIA PACIFIC FACIAL AESTHETIC DEVICES IN MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 21 ASIA PACIFIC DERMAL FILLERS IN MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 22 ASIA PACIFIC AESTHETIC IMPLANTS IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 ASIA PACIFIC AESTHETIC IMPLANTS IN MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 24 ASIA PACIFIC BREAST AUGMENTATION IN MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 25 ASIA PACIFIC AESTHETIC DENTAL IMPLANTS IN MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 26 ASIA PACIFIC SKIN AESTHETIC DEVICES IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 ASIA PACIFIC SKIN AESTHETIC DEVICES IN MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 28 ASIA PACIFIC MEDICAL AESTHETICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 29 ASIA PACIFIC ANTI-AGING AND WRINKLES IN MEDICAL AESTHETICS MARKET, BY REGION , 2021-2030 (USD MILLION)
TABLE 30 ASIA PACIFIC FACIAL AND SKIN REJUVENATION IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 ASIA PACIFIC BREAST ENHANCEMENT IN MEDICAL AESTHETICS MARKET, BY REGION , 2021-2030 (USD MILLION)
TABLE 32 ASIA PACIFIC BODY SHAPING AND CELLULITE IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 ASIA PACIFIC TATTOO REMOVAL IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 34 ASIA PACIFIC VASCULAR LESIONS IN MEDICAL AESTHETICS MARKET, BY REGION , 2021-2030 (USD MILLION)
TABLE 35 ASIA PACIFIC SEARS, PIGMENT LESIONS, RECONSTRUCTIVE IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 36 ASIA PACIFIC PSORIASIS AND VITILIGO IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 37 ASIA PACIFIC OTHERS IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 38 ASIA PACIFIC MEDICAL AESTHETICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 39 COSMETIC CENTERS IN MEDICAL AESTHETICS MARKET, BY REGION , 2021-2030 (USD MILLION)
TABLE 40 ASIA PACIFIC DERMATOLOGY CLINICS IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 41 ASIA PACIFIC HOSPITALS IN MEDICAL AESTHETICS MARKET, BY REGION , 2021-2030 (USD MILLION)
TABLE 42 ASIA PACIFIC MEDICAL SPAS AND BEAUTY CENTERS IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 43 ASIA PACIFIC MEDICAL AESTHETICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 44 ASIA PACIFIC DIRECT TENDER IN MEDICAL AESTHETICS MARKET, BY REGION , 2021-2030 (USD MILLION)
TABLE 45 ASIA PACIFIC RETAIL IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)
Abbildungsverzeichnis
FIGURE 1 ASIA PACIFIC MEDICAL AESTHETICS MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC MEDICAL AESTHETICS MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC MEDICAL AESTHETICS MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC MEDICAL AESTHETICS MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC MEDICAL AESTHETICS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC MEDICAL AESTHETICS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC MEDICAL AESTHETICS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA PACIFIC MEDICAL AESTHETICS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 ASIA PACIFIC MEDICAL AESTHETICS MARKET: SEGMENTATION
FIGURE 10 THE INCREASE IN THE AGING POPULATION ASIA PACIFICLY IS EXPECTED TO DRIVE THE ASIA PACIFIC MEDICAL AESTHETICS MARKET GROWTH IN THE FORECAST PERIOD
FIGURE 11 THE AESTHETIC LASER DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC MEDICAL AESTHETICS MARKET IN 2023 & 2030
FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC MEDICAL AESTHETICS MARKET
FIGURE 13 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY PRODUCT TYPE, 2022
FIGURE 14 ASIA PACIFIC MEDICAL AESTHETICS MARKET : BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 15 ASIA PACIFIC MEDICAL AESTHETICS MARKET : BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 16 ASIA PACIFIC MEDICAL AESTHETICS MARKET : BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 17 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY APPLICATION, 2022
FIGURE 18 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 19 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 20 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 21 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY END USER, 2022
FIGURE 22 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 23 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY END USER, CAGR (2023-2030)
FIGURE 24 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY END USER, LIFELINE CURVE
FIGURE 25 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 26 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 27 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 28 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 29 ASIA-PACIFIC MEDICAL AESTHETICS MARKET: SNAPSHOT (2022)
FIGURE 30 ASIA-PACIFIC MEDICAL AESTHETICS MARKET: BY COUNTRY (2022)
FIGURE 31 ASIA-PACIFIC MEDICAL AESTHETICS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 32 ASIA-PACIFIC MEDICAL AESTHETICS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 33 ASIA-PACIFIC MEDICAL AESTHETICS MARKET: BY TEST TYPE (2023-2030)
FIGURE 34 ASIA PACIFIC MEDICAL AESTHETICS MARKET: COMPANY SHARE 2022 (%)
Forschungsmethodik
Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.
Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.
Anpassung möglich
Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.
